Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07804693
What this trial is testing

Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Vascular DiseaseHigh Altitude+2 more
Silvia Ulrich Somaini 20
Not applicableNot Yet RecruitingNCT06117644
What this trial is testing

The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC

Who this might be right for
Non Small Cell Lung CancerEGFR Gene MutationNon Small Cell Lung Cancer Stage IIIA+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Large-scale testing (Phase 3)Ended earlyNCT02654587
What this trial is testing

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

Who this might be right for
Non Small Cell Lung Cancer
OSE Immunotherapeutics 219
Large-scale testing (Phase 3)Study completedNCT02251964
What this trial is testing

Rituximab in Interstitial Pneumonitis

Who this might be right for
Lung Diseases, InterstitialPneumonitis, Interstitial
Human Adams 20
Early research (Phase 1)Not Yet RecruitingNCT06067776
What this trial is testing

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Jonathan Riess 36
Not applicableUnknownNCT03766490
What this trial is testing

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung
The First Affiliated Hospital of Soochow University 66
Not applicableUnknownNCT02041468
What this trial is testing

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Jewish General Hospital 29
Not applicableLooking for participantsNCT04977791
What this trial is testing

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Chest Hospital 250
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Not applicableStudy completedNCT00083798
What this trial is testing

Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland

Who this might be right for
Sleep Apnea SyndromesLung DiseasesInsulin Resistance
University of Pennsylvania 2,843
Not applicableActive Not RecruitingNCT03404258
What this trial is testing

ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis

Who this might be right for
Single-ventriclePulmonary Vascular Resistance AbnormalitySuperior Cavo-Pulmonary Anastomosis+2 more
University of Colorado, Denver 50
Not applicableLooking for participantsNCT07751536
What this trial is testing

CtDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase

Who this might be right for
Leptomeningeal Metastasis From Lung Cancer
Shuanghu Yuan 84
Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07825259
What this trial is testing

Itraconazole and Posaconazole for Chronic Pulmonary Aspergillosis

Who this might be right for
Chronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh 220
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Very early researchNot Yet RecruitingNCT07338123
What this trial is testing

Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli

Who this might be right for
Pneumonia
Chinese PLA General Hospital 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944772
What this trial is testing

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 247
Testing effectiveness (Phase 2)Study completedNCT00248365
What this trial is testing

Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)

Who this might be right for
Graft vs Host Disease
Kiadis Pharma 20
Not applicableStudy completedNCT06141837
What this trial is testing

Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)

Who this might be right for
Pseudomonas AeruginosaCOVID-19
Central Hospital, Nancy, France 51
Next Page